Pomalidomide

Specificity Recognizes Glycoprotein Po. Po is the major glycoprotein in peripheral myelin Immunogen Synthetic peptides from human/mouse Po.

POU domain, class 6, transcription factor 1 (POU6F1) is also called Brain-specific homeobox/POU domain protein 5 (Brn-5), and mPOU homeobox protein. POU6F1 is a nuclear transcription factor that binds preferentially to a variant of the octamer

Application Protein degrader building block Opto-pomalidomide enables the synthesis of molecules for light-induced targeted protein degradation and PROTAC &#174 (proteolysis-targeting chimeras) research. This conjugate contains a Cereblon (CRBN)

Application Protein degrader builiding block Pomalidomide-C 9 -CO 2 H enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon (CRBN)-recruiting

Application Protein degrader builiding block Pomalidomide-PEG 1 -Alkyne enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon

Application Protein degrader builiding block Pomalidomide-PEG3-Alkyne enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon (CRBN)-recruiting

Application Protein degrader builiding block Pomalidomide-PEG 3 -CO 2 H enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon

Application Protein degrader builiding block Pomalidomide-PEG 5 -Alkyne enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate contains a Cereblon